À propos du dépistage du cancer du col utérin

Revue Medicale de la Suisse Romande

Volumn 117, Issue 8, 1997, Pages 589-591

  Delaloye, Jean François ^a   De Grandi, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; CANCER STAGING; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; MIDDLE AGED; REVIEW; SWITZERLAND; TIME; UTERINE CERVIX TUMOR;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; SWITZERLAND; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0031201219     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Levi F., Te V.C., Randimbison L., La Vecchia C.: Trends in cancer incidence and mortality in Vaud, Switzerland 1974-1993. Ann. Oncol., 7: 497-504, 1996.
2. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Acta Cytol., 37: 115-123, 1996.
3. Östor A.G.: National history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol., 12: 186-192, 1993.
4. Kiviat N.: Natural history of cervical neoplasia: overview and update. Am. J. Obstet. Gynecol., 175: 1099-1094, 1996.
5. Kaufman R.H.: Atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion: diagnostic criteria and management. Am. J. Obstet. Gynecol., 175: 1120-1128, 1996.
6. Cox J.T., Lorincz A.T., Schiffman M.H., Sherman M.E., Cullen A., Kurman R.J.: Human papillomavirus testing by hybrid capture appears to be useful in traging women with a cytologic diagnosis of atypical squamous cell of undetermined significance. Am. J. Obstet. Gynecol., 172: 946-954, 1995.
7. Soost H.J., Lange H.J., Lehmacher W., Ruffing-Kullmann B.: The validation of cervical cytology: sensitivity, specificity, and predictive value. Acta Cytol., 35: 8-14, 1991.
8. Koss L.G.: The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA, 261: 737-743, 1989.
9. DeMay R.M.: Cytopathology of false negatives preceeding cervical carcinoma. Am. J. Obstet. Gynecol., 175: 1110-1113, 1996.
10. Davey D.D., Nielsen M.L., Rosenstock W., Kline T.S.: Terminology and specimen adequacy in cervicovaginal cytology: the College of American Pathologists interlaboratory Comparison Program experience. Arch. Pathol. Lab. Med., 116: 903-907, 1992.
11. Dodd L.G., Sneige N., Villareal Y. et al.: Quality-assurance study of simultaneously sampled, non correlating cervical cytology and biopsies. Diagn. Cytopathol., 9: 138-144, 1993.
12. Elias A., Linthorst G., Bekker B., Vooijs P.C.: The sigificance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol., 27: 225-229, 1983.
13. Mauney M., Eide D., Sothan J.: Rates of condyloma and dysplasia in Papanicolaou smears with and without endocervical cells. Diagn. Cytopathol., 6: 18-21, 1990.
14. McGoogan E., Reith A.: Would monolayers provide more representative samples and improved preparations for cervical screening? Overview and evaluation of systems available. Acta Cytol., 40: 107-119, 1996.
15. Mango L.J.: Reducing false-negatives in clinical practice: the role of neural network technology. Am. J. Obstet. Gynecol., 175: 1114-1119-656, 1996.
16. Ferenczy A., Franco E., Arseneau J., Wright T.C., Richart R.M.: Diagnostic performance of hybrid capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am. J. Obstet. Gynecol., 175: 651-656, 1996.
17. Hatch K.D., Schneider A., Abdel-Nour M.W.: An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am. J. Obstet. Gynecol., 172: 1150-1157, 1995.
18. Anderson G.H., Boyes D.A., Benedet J.L., Le Riche J.C., Matisic J.P., Suen K.S., Worth A.J., Millner A., Bennett O.M.: Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. BMJ, 296: 975-978, 1988.
19. Hristova L., Hakama M.: Effect of screening for cancer in the nordic countries on deaths, costs and quality of life up to the year 2017. Acta Oncol., 36 (Suppl 9): 1-60, 1997.
20. Parkin D.M.: Screening for cervix cancer in developing countries. In: A.B. Miller, J. Chamberlain, N.E. Day, M. Hakama and P.C. Prorok (eds), Cancer screening, 184-198, Cambridge University Press, Cambridge 1991.